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Abstract
Background: Chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-
seq) has recently been used to identify the modification patterns for the methylation and
acetylation of many different histone tails in genes and enhancers.
Results: We have extended the analysis of histone modifications to gene deserts, pericentromeres
and subtelomeres. Using data from human CD4+ T cells, we have found that each of these non-
genic regions has a particular profile of histone modifications that distinguish it from the other non-
coding regions. Different methylation states of H4K20, H3K9 and H3K27 were found to be
enriched in each region relative to the other regions. These findings indicate that non-genic regions
of the genome are variable with respect to histone modification patterns, rather than being
monolithic. We furthermore used consensus sequences for unassembled centromeres and
telomeres to identify the significant histone modifications in these regions. Finally, we compared
the modification patterns in non-genic regions to those at silent genes and genes with higher levels
of expression. For all tested methylations with the exception of H3K27me3, the enrichment level
of each modification state for silent genes is between that of non-genic regions and expressed
genes. For H3K27me3, the highest levels are found in silent genes.
Conclusion: In addition to the histone modification pattern difference between euchromatin and
heterochromatin regions, as is illustrated by the enrichment of H3K9me2/3 in non-genic regions
while H3K9me1 is enriched at active genes; the chromatin modifications within non-genic
(heterochromatin-like) regions (e.g. subtelomeres, pericentromeres and gene deserts) are also
quite different.
Background
The chromatin state and transcription level of a chromo-
somal region has been found to be related to modifica-
tions of histones [1,2] as well as DNA [3,4]. The
fundamental structural unit of chromatin is the nucleo-
some, which is formed by wrapping DNA around a his-
tone octamer consisting of two copies each of four core
histone proteins (H2A, H2B, H3, and H4). The tails of
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these histones can be modified in a variety of ways that
relate to chromatin condensation and gene expression[2].
Different histone residues can be methylated, acetylated,
phosphorylated or ubiquitinated to either directly change
the chromatin structure or allow for the binding of spe-
cific transcription factors [5].
The acetylation and methylation states of various lysine
residues have been extensively investigated. Due to the
reactive nature of the amine group on the side chain of
lysine, it can be acetylated or mono-, di- or tri- methyl-
ated. Enrichment for acetylated histones has been found
to correlate with euchromatic and gene-coding regions
[6,7]. In contrast, certain methylations are associated with
activation and others with repression. The most exten-
sively characterized activating methylation is H3K4[8-10],
while the H3K9 [11-13] and H3K27 [14-16] methylations
are thought to lead to repression and inactivation.
Recently, though, mono-methylations of H3K27 and
H3K9 have been found to be enriched in active genes [17].
Using antibodies with specificity for a particular methyla-
tion state, cells have been profiled separately for mono-,
di-, and tri- methylation of the same residue. These com-
parisons were originally performed using mass-spectros-
copy and comparisons of staining patterns[18-20]. Since
these studies relied on comparisons of staining patterns,
they were only able to produce low-resolution results that
could not be linked to sequence positions. More recently,
the ChIP-chip [21] and ChIP-seq [17] techniques have
been utilized for high-resolution sequence level profiling
of histone modifications in mammalian genomes[22,17].
These techniques utilize chromatin immunoprecipitation
coupled with either tiling microarray hybridization or
high-throughput sequencing to determine the genomic
locations of a particular modification. It is now possible
to obtain resolution on the level of individual nucleo-
somes. Because histone modifications act on individual
nucleosome and there may be modification differences
between adjacent nucleosomes, this level of resolution is
highly informative.
The most comprehensive profiling of histone modifica-
tions has been performed in CD4+ T cells[17,23]. The
genome-wide locations at a single nucleosome level reso-
lution of 38 different histone methylations and acetyla-
tions were profiled, including different levels of
methylation of the same residue. In these studies, the
modification profiles surrounding the promoters of genes
with different levels of expression were examined. Basic
comparisons between the different modifications were
performed in the region surrounding annotated genes,
but here we are reporting the results of an extension of our
initial studies [17,23] to non-genic regions of the human
genome.
In particular, we wanted to investigate histone modifica-
tions in three important largely non-coding regions of the
genome: pericentromeres, subtelomeres, and gene
deserts. These regions are mostly non-coding, but little
work has been performed to characterize and differentiate
them with regard to histone modifications. Using the
identified genome-wide locations for histone methyla-
tions and acetylations in CD4+ T cells, we have identified
the modifications that are strongly enriched in pericentro-
meres, subtelomeres, and intergenic regions (we have
excluded all known genes in those regions). We have also
used consensus repeat sequences to analyze histone mod-
ifications present in the unassembled portions of telom-
eres and centromeres.
Results
Characterization of histone modifications enriched in 
pericentromeres, subtelomeres or gene deserts
To characterize the histone modifications that are
enriched in different regions of the genome, we first
obtained the locations of each type of region. Our deter-
minations were made based upon gene annotations (see
Methods and Figure 1 for details). Pericentromeres were
defined for each chromosome as the region between the
two genes most proximal to the centromeric gap in the
genome assembly. From this region, the 10 kb nearest to
each of the genes was removed since it could contain reg-
ulatory elements for the genes. Subtelomeres designations
from [24] were used as a starting point. If a gene was
found in a subtelomere, the gene was removed along with
the 10 kb surrounding it on each side. Gene deserts were
defined as regions of greater than 1 Mb between two adja-
cent genes, with the 10 kb proximal to each gene removed.
From all three types of regions, any known Pol II binding
sites[17] or DNase I hypersensitive sites [25] with 100 bp
flanking regions were removed in order to exclude regions
that may be related to the adjacent genes.
In each of these genomic regions, we determined the sta-
tistically significant histone modifications. First, the aver-
age number of tags for each modification in each type of
region was determined. Random samples of the genome
having the same size as each type of region were then
taken and the number of tags for each modification was
determined for the samples. By comparing the actual
count to the counts in the random samples, an empirical
p-value for significance could be determined (see meth-
ods for details). The results of this analysis are shown in
Table 1. All of the modifications shown are significant
with a q-value < 0.05, with the full data listed in Addi-
tional File 1.
The results for pericentromeres are intriguing. The enrich-
ment of H3K9me3 is expected, as it is a known mark for
constitutive heterochromatin. H4K20me3 is a knownBMC Genomics 2009, 10:143 http://www.biomedcentral.com/1471-2164/10/143
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mark of repressed chromatin and therefore it would be
expected to be enriched in non-genic regions of the
genome. Surprisingly, it is only found strongly in pericen-
tromeres and in no other type of non-genic region. The
appearances of H4R3me2 and H3R2me2 as significant
modifications in pericentromeres are likewise interesting.
Methylation of H4R3 has been generally correlated with
expression and active chromatin [26,27]. But, as with
other histone modifications, no distinction has been
made between the two methylation states of H4R3,
H4R3me1 and H4R3me2. Therefore, H4R3me2 could be
a signal of pericentromeres while H4R3me1 could be a
signal of active genes. This is supported by the fact that
H4R2me2 levels were not found to have a preferential
enrichment at either active or silent promoters [17].
H3R2me2 has been found to impede the binding of effec-
tor proteins to H3K4me3 and thus to control gene expres-
sion [28]. It is possible that the significant levels of
H3R2me2 in pericentromeres are important in preventing
the expression of genes in those loci. These four modifica-
A diagram outlining the analysis that was performed on the data Figure 1
A diagram outlining the analysis that was performed on the data. The diagram uses the example of gene deserts to 
describe the analysis, but the same techniques were used for pericentromeres, subtelomeres and silent, medium expression 
and high expression genes.
Table 1: Significant Modifications in Genomic Regions
Pericentromeres H3K9me2, H3K9me3, H3R2me2, H4K20me3, H4R3me2
Gene Deserts H3K9me2, H3K9me3
Subtelomeres H2AK5ac, H3K14ac, H3K27me2, H3K27me3, H3R2me1
Statistically significant modifications in pericentromeres, telomeres and gene deserts. Modifications listed are significant at a q-value of 0.05, with the 
full data listed in Additional File 1.BMC Genomics 2009, 10:143 http://www.biomedcentral.com/1471-2164/10/143
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tions are all strongly correlated with each other within
pericentromeric regions indicating that they are likely to
be found on the same nucleosomes.
For gene deserts, the di- and tri methylations of H3K9me3
were found to be significantly enriched, as would be
expected [29]. Distinctly lacking, were H3K27me3 and
H3K9me1. This absence could be due to the presence of
H3K27me3 and H3K9me1 in silent and active genes (see
below). For subtelomeres, the repressive marks
H3K27me2/3 were found to be enriched along with two
acetylations that are marks of activation, H2AK5ac and
H3K14ac.
H4K20 and H3K9 methylation levels are varied in 
pericentromeres, subtelomeres and gene deserts
To further characterize the histone modifications in differ-
ent non-genic regions, we compared the multiple methyl-
ation states of individual residues in each region. The
number of tags identified for each methylation state of
H4K20 and H3K9 in pericentromeres, subtelomeres and
gene deserts were counted and the results are shown in
Figure 2. For H4K20me, the differences between the types
of chromatin are significant. In each region, levels of
H4K20me1 are minimal and invariant. One possible rea-
son for this is that H4K20me1 is a marker of active genes
[17,30] and it is depleted in constitutive heterochromatin.
The reverse is found for H4K20me3 which has been found
to associate with constitutive heterochromatin [31]. In
pericentromeres, the level of H4K20me3 is over 40 times
the level of H4K20me1. This difference decreases in gene
deserts and it is lowest in subtelomeres where the level of
H4K20me3 is only double the level of H4K20me1. This
indicates that H4K20me3 may be important for pericen-
tromeres.
We next compared the three levels of methylation of
H3K9 (Figure 2B). The levels of H3K9me2/3 have been
found to be enriched in non-genic regions, while
H3K9me1 levels are enriched at active genes [17]. We
found that for each type of non-genic region the order of
enrichment levels is the same with H3K9me3>
H3K9me2>H3K9me1. While the order is the same, the
ratio between the methylation levels varies. In pericentro-
meres, the levels of H3K9me3 are almost double those of
H3K9me2. This difference is greatly decreased in subte-
lomeres where the levels are similar and within one stand-
ard error of the mean (see error bars). In pericentromeres,
the combined levels of H3K9me2 and H3K9me3 are 11
times those of H3K9me1. This is reduced to 4 times the
level of H3K9me1 in subtelomeres.
Analysis of histone modifications at centromeric and 
telomeric repeats
Since large regions of the centromeres and telomeres of
the human genome are not included in the genome
assembly, they could not be accurately probed by our
techniques. To probe these regions, we have used a
A comparison of the enrichment of different levels of methylation at the same residue in gene deserts, pericentromeres and  subtelomeres Figure 2
A comparison of the enrichment of different levels of methylation at the same residue in gene deserts, peri-
centromeres and subtelomeres. The mean has been plotted and the error bars show plus and minus one standard error 
of the mean. All of the data has been normalized to the number of counts of each modification in the genome, so the genomic 
average for each mark is 1.BMC Genomics 2009, 10:143 http://www.biomedcentral.com/1471-2164/10/143
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technique similar to that previously used for studying his-
tone modifications at repetitive regions in the mouse
genome [32]. As a proxy for the actual genome sequences
at repetitive locations, consensus repeat sequences are
used. We have taken all of the reads for each methylation
and determined the percentage of them that aligned either
to telomere or centromere consensus repeat sequences.
Since the percentages of repeats were calculated and com-
pared, no normalization for differences in antibody spe-
cificity or number of sequenced tags were required. The
percentage is a self-normalizing calculation. (see Methods
for details)
For centromeres, the most represented modifications are
H4K20me3 and H3K9me3 and the least significant mod-
ifications are H3K4me1 and H4K20me1. Both
H4K20me3 and H3K9me3 are known to be associated
with constitutive heterochromatin[29,33] and were also
found to be significantly enriched in pericentromeres.
This indicates that centromeres have heterochromatic
characteristics and may require these histone modifica-
tions to prevent expression. For telomeres, the most sig-
nificant modifications are H2BK5me1 and H3K4me3 and
the least significant are H3K36me3 and H3K9me3. The
finding of these two activating modifications to be the
strongest in telomeres is interesting and is likely to be
related to the recent finding of RNA polymerase II tran-
scription at mouse[34] and human[35] telomeres. The
lack of H3K9me3 also indicates that telomeres are not
consistent with other non-coding regions of the human
genome. In contrast to the middle of a chromosome
where pericentromeres and centromeres have similar
enriched histone modifications, the ends of chromo-
somes at subtelomeres and telomeres have different mod-
ifications. We also found that a much larger percentage of
the tags matched the centromeric repeats than the telom-
eric repeats. The percentage of tags matching the centro-
meric repeats range from 0.02% to 0.8%, while the range
for telomeric repeats is from 10e-4% to 10e-3 %. This can
be explained by the much larger percentage of the genome
contained in centromeres than in telomeres [36,37].
Because the percentage of reads was compared rather than
the raw numbers of reads, this result should not be
affected by differences in sequencing depth.
Determination of modifications with statistically 
significant enrichment in different regions of the genome
We next decided to compare our findings for non-genic
regions to the genic portions of the genome. Using com-
parisons to random samples of the genome (see above
and methods), we determined the histone modifications
statistically significant in silent genes, medium expression
genes, high expression genes, and a combined set of all
genes without regard to expression. The complete list of
significant modifications is summarized in Table 2. All
modifications listed in this table are significant at a q-
value of 0.05 and a complete list of all modifications with
their mean counts and empirical p-values and q-values are
in Additional File 1. When all of the genic regions without
regard to expression were tested, all of the acetylations
and some of the methylations were found to be signifi-
cant. Interestingly, when the genes were divided into
groups by expression level, different modifications were
found to be significant for each level of expression. The
least well-characterized groups are silent genes and non-
genic regions which each only have a few modifications
significantly enriched. In contrast, there are many modifi-
cations that are preferentially associated with active genes.
H3K9me2/3 and H3K9me1 have variant levels of 
enrichment in non-genic regions and in genes
Since the significance analysis found H3K9me2 and
H3K9me3 to be enriched in non-genic regions and
H3K9me1 enriched at active genes, we wanted to further
investigate the relationship between H3K9 methylation
state and expression level. In general, H3K9 methylation
has been considered to be an indicator of inactive and
silent chromatin[13,11,12], but increased levels of
Table 2: Significant Modifications in Genes with different levels of expression and Non-genic Regions
High Expression Genes H2AK5ac, H2AK9ac, H2AZ, H2BK120ac, H2BK12ac, H2BK20ac, H2BK5ac, H2BK5me1, H3K14ac, H3K18ac, 
H3K23ac, H3K27ac, H3K27me1, H3K36ac, H3K36me3, H3K4ac, H3K4me1, H3K4me2, H3K4me3, H3K79me1, 
H3K79me2 H3K79me3 H3K9ac, H3K9me1, H3R2me1, H3R2me2 H4K12ac, H4K16ac, H4K20me1, H4K5ac, 
H4K8ac, H4K91ac
Medium Expression H2AK5ac, H2AK9ac, H2AZ, H2BK120ac, H2BK12ac, H2BK20ac, H2BK5ac, H2BK5me1, H3K14ac, H3K18ac, 
H3K23ac, H3K27ac, H3K27me1, H3K27me2, H3K27me3, H3K36ac, H3K36me3, H3K4ac, H3K4me1, 
H3K4me2, H3K4me3, H3K79me1, H3K79me2, H3K79me3, H3K9ac, H3K9me1, H3R2me1, H3R2me2, 
H4K12ac, H4K16ac, H4K20me1, H4K20me3, H4K5ac, H4K8ac, H4K91ac, H4R3me2
Silent Genes H2AZ, H3K27me2, H3K27me3, H3K9me2
Non-genic Regions H3K9me2, H3K9me3
Statistically significant modifications in different regions of the genome. Modifications listed are significant at a a-value of 0.05, with the full data listed 
in Additional File 1.BMC Genomics 2009, 10:143 http://www.biomedcentral.com/1471-2164/10/143
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H3K9me1 are found consistently in the gene body of
active genes [17]. Interestingly, certain active genes have
also been found to have H3K9me3[38-40].
To investigate the roles of mono-, di- and tri-methylated
H3K9, we compared the levels of enrichment of each
modification in overall non-genic regions in addition to
genes with different levels of activity (Figure 3A). It was
found that the overall profiles for H3K9me2 and
H3K9me3 are highly similar (Pearson correlation of
0.99). The enrichment for these two modifications was
highest in non-genic silent regions and decreased as the
activity of the regions increased. In contrast, a completely
opposite profile was found for H3K9me1. As the activity
level for genomic regions increased, the level of H3K9me1
increased greatly. These findings indicate that H3K9me is
not a monolithic modification and H3K9me1 is distinct
from H3K9me2/3.
The three levels of H3K4 methylation are all activating 
marks, but H3K4me3 is the least enriched in active genes 
relative to inactive genes
H3K4me has long been considered an activating mark for
chromatin, but differences between H3K4me2/3 and
H3K4me1 have been found[8,17,41]. To compare the
enrichments of H3K4me1, H4K4me2, and H3K4me3 in
broader regions, we compared the counts of each modifi-
cation in regions of the genome (Figure 3B). This figure
suggests that the enrichment patterns for H3K4me1, me2,
and me3 are almost congruent (Pearson correlation of
0.99) with each other indicating that all three levels of
methylation of H3K4 are equally important determinants
of expression level as activating marks. The only regions of
the genome having a significant difference between the
modifications of H3K4 are highly expressed genes. In
these regions H3K4me1 and H3K4me2 are enriched at
higher levels than H3K4me3
The methylation states of H3K27 each have a distinct 
profile
Different methylation states of H3K27 are found to be sig-
nificant in distinct parts of the genome (Table 2). Because
of this variation, we wanted to determine how the differ-
ent modification states are related to genes with different
levels of expression. We determined the number of counts
for each methylation state of H3K27me3 in each type of
region in the genome. The resulting plots are shown in
Figure 4.
It was found that the levels of H3K27me3 are most
enriched at silent genes. The levels of this modification is
similarly minimal in both non-genic regions and active
genes. Rather than having an enrichment level that is
either correlated or anti-correlated with expression, it has
A. A comparison of the profiles of the different levels of methylation of H3K9 from non-genic regions to high expression genes Figure 3
A. A comparison of the profiles of the different levels of methylation of H3K9 from non-genic regions to high 
expression genes. The points represent the mean value with the error bars showing the standard error. B. A comparison of 
the profiles of the different levels of methylation of H3K4 from non-genic regions to high expression genes. All of the data has 
been normalized to the number of counts of each modification in the genome, so the genomic average for each mark is 1.BMC Genomics 2009, 10:143 http://www.biomedcentral.com/1471-2164/10/143
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a parabolic profile with the peak in silent genes. This find-
ing is especially interesting when considered in concert
with the profiles of the other levels of methylation of
H3K27 and their presumed functions. Each level of meth-
ylation of these two residues has a completely distinct
profile. This diversity is much greater than what was
found for any other histone residues including H3K4,
H4K9 and H4K20.
Discussion
We have analyzed histone modification patterns in peri-
centromeres, subtelomeres, and gene deserts. It was found
that each region has a distinct histone modification pro-
file even though they are all traditionally considered to be
constitutive heterochromatin or heterochromatin-like
[42]. This is not unexpected since each of them has a dis-
tinct function. Pericentromeres are involved in the cohe-
sion of sister chromatids during cell division [43],
subtelomeres maintain chromosome stability [24,44] and
gene deserts do not have a well defined function but they
may contain long-range regulators of gene function
[45,46] or structural regions such as the nuclear matrix
attachment sites [47,48]. Each of these functions is per-
formed by a specific set of DNA binding proteins and thus
should be associated with distinct histone modifications.
One possibility for the discrepancy between H3K9me3
levels in gene deserts and pericentromeres as compared to
telomeres relates to their locations in the genome. Peri-
centromeres and gene deserts are in the middle of a chro-
mosome between genes (even though the genes may be at
a great distance) and therefore they need H3K9me3 which
will interact with HP1 [49] to prevent transcription from
occurring. Subtelomeres do not require such an enrich-
ment of H3K9me3.
A further conclusion from the results in Table 1, is that the
modifications found in gene deserts are a subset of the
modifications that are found at pericentromeres. Both
contain repressive H3K9me2/3, but pericentromeres also
have H3R2me2, H4K20me3 and H4R3me2. This differ-
ence may be due to the replication associated functions of
pericentromeres [50]. This is in addition to the require-
ment of a constitutive heterochromatin sequence at cen-
tromeres [43].
A recent study [32] looked at constitutive heterochromatic
regions of the genome by aligning ChIP-seq reads to con-
sensus sequences for repetitive elements and found that
H3K9me3 and H4K20me3 were strongly enriched. We
have reached a similar conclusion, but were able to sepa-
rate the centromeric and telomeric regions and distin-
guish the modifications that are enriched in each of these
regions. We found that the enrichment of H3K20me3 in
non-coding regions is largely due to its high level in peri-
centromeres and that it is found at lower levels in subte-
lomeres and gene deserts.
The comparisons between non-coding regions and genes
with different levels of expression have allowed us to
determine the histone modifications enriched in each
region. We have found that silent genes have a distinct his-
tone modification profile that is not merely an intermedi-
ate between genes with high levels of expression and non-
genic regions. Non-coding regions are characterized by
high levels of H3K9me2/3 whereas silent genes are char-
acterized by H3K27me3. This is contrary to previous stud-
ies that have grouped H3K9me2/3 and H3K27me3 as
repressive modifications [29,51] without identifying sig-
nificant differences between them. Our higher resolution
and sharper distinction between the genomic regions
allowed for this differentiation.
Conclusion
We have found that regions of the genome that do not
contain actively expressed genes do not have a monolithic
histone modification profile. Silent genes as well as differ-
ent sub-categories of non-coding regions including gene
deserts, subtelomeres and pericentromeres each have dif-
ferent significantly enriched histone modifications. We
have also determined the histone modifications at highest
levels in non-assembled telomeres and centromeres.
Profiles of different levels of methylation for H3K27 Figure 4
Profiles of different levels of methylation for H3K27. 
The points represent the mean value with the error bars 
showing the standard error. Each level of methylation of this 
residue has a distinct profile with the tri-methylation most 
highly enriched in silent genes. Even though the levels of the 
three types of H3K27me are indistinguishable in silent genes, 
the levels of H3K27me3 are clearly higher there than any-
where else. All of the data has been normalized to the 
number of counts of each modification in the genome, so the 
genomic average for each mark is 1.BMC Genomics 2009, 10:143 http://www.biomedcentral.com/1471-2164/10/143
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Additionally, we have found that for each histone residue
studied different methylation states are enriched in differ-
ent parts of the genome. It is therefore an oversimplifica-
tion to speak about the function of methylation of a




The chromatin modification data was obtained from
[23,17]. The histone modifications analyzed were:
H2AK5ac, H2AK9ac, H2AZ, H2BK120ac, H2BK12ac,
H2BK20ac, H2BK5ac, H2BK5me1, H3K14ac, H3K18ac,
H3K23ac, H3K27ac, H3K27me1, H3K27me2,
H3K27me3, H3K36ac, H3K36me3, H3K4ac, H3K4me1,
H3K4me2, H3K4me3, H3K79me1, H3K79me2,
H3K79me3, H3K9ac, H3K9me1, H3K9me2, H3K9me3,
H3R2me1, H3R2me2, H4K12ac, H4K16ac, H4K20me1,
H4K20me3, H4K5ac, H4K8ac, H4K91ac, H4R3me2.
Determination of genomic regions and types of chromatin
The genic regions of the genome were the UCSC Known
Genes (April 2007 release). To remove redundancy, splice
variants of genes were combined and each exon was only
included once in the set. Additionally, only genes that had
accurate unambiguous mappings to Affymetrix U133 Plus
2.0 arrays were used. This procedure resulted in a list of
12,544 genic regions. For all of the analyses, the gene
region refers to all of the sequence from the start to end of
transcription.
The genes were divided into three groups based upon their
expression level in CD4+ cells[52]. The high expression
genes are the 1000 genes with the highest level of expres-
sion, the medium expression genes are the middle 1000
genes when the genes are sorted by expression and the
silent genes are the 1000 genes with the lowest level of
expression.
The gene desert regions were determined by first identify-
ing adjacent genes in the genome with a 1 Mb break
between adjacent genes. From these regions, the outer 10
kb on each end that could contain regulatory elements for
the neighboring genes were excluded. To further purify
the sequence, any known DNase hypersensitive sites[25]
and RNA Pol II binding sites[17] were removed along
with 100 bp flanking regions on each side of these sites
The subtelomeric regions were taken from[53]. The origi-
nal data from that manuscript http://www.wistar.org/
riethman/ contained genomic coordinates for the July
2003 (hg16) build of the human genome. These coordi-
nates were mapped onto the Mar. 2006 (hg18) assembly
using the UCSC LiftOver tool. Of the 21 Mb of sequence
that were identified in hg16, 13 Mb could be accurately
mapped to hg18.
The pericentromeric regions were determined based upon
the centromere locations identified in the UCSC Genome
Browser. The sequence between the two most proximal
genes on either side of the pericentromere was obtained.
From this sequence, any known DNase hypersensitive
sites [25] and RNA Pol II binding sites [17] were removed
along with 100 bp flanking regions on each side of these
sites.
In order to refine the regions that were being used and to
eliminate the number of false negative that were found,
we utilized the identified nucleosome locations within
the human genome [52] as a control. For a histone to be
modified, there needs to be a nucleosome present, thus
any region in the genome that is lacking nucleosomes by
definition, must lack all histone modifications. In addi-
tion, there are regions throughout the human genome
that cannot accurately be mapped accurately using the
short reads [54,55]. We therefore only included those
regions of the genome in which nucleosomes were found.
We mapped all of the nucleosome reads from [52] to the
human genome and then extended the read length to 150
bp to include the entire length of the nucleosome. This
resulted in an effective genome size of 2,171,857,609 bp.
The percentages of each type of region that was covered by
nucleosomes and therefore analyzed are in Additional
File 2.
Determination of counts in particular regions
The determination of the number of counts for a particu-
lar modification in a genome region will be outlined
using the example of H3K4me3 and high expression
genes. This same method was used for each modification
and each type of genomic region. All of the high expres-
sion genes were extracted and divided into non-overlap-
ping 1 kb windows. For each window, the number of
H3K4me3 tags whose middle was within the window was
counted. This count was then normalized by dividing it by
the average number of counts for H3K4me3 in 1 kb win-
dows in the whole genome covered by nucleosomes.
Through this normalization step, the counts of different
modifications were made comparable. The raw counts are
affected by differences in the affinities between antibodies
for different modifications and therefore have different
distributions. A normalized count was determined for
each window and the mean and standard error of the
mean were calculated. This mean appears in the graphs as
the normalized count per kb for H3K4me3 in high expres-
sion genes. The standard error of the mean is shown in the
error bars.
Statistical Significance of Modifications
The average counts of each modification in all regions of
a particular type were compared with random samples of
the nucleosome filled portions of the genome (see
above). The rank of the actual count in the distribution ofBMC Genomics 2009, 10:143 http://www.biomedcentral.com/1471-2164/10/143
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the randomized counts gave an empirical p-value. Using
the example of H3K4me3 in high expression genes this
will be illustrated. The total count of H3K4me3 marks in
the entire gene body from the TSS to the end of transcrip-
tion for all high expressed genes was determined. Then,
ten thousand random samples of the nucleosome-filled
genome each having the same total number of bases as
that of all of the high expressed genes were made. For each
random sample, the total number of counts of H3K4me3
was determined. These sample counts were used to create
a null distribution for the number of H3K4me3 tags that
would be found in a random portion of the genome cov-
ered by nucleosomes. The actual count was then com-
pared to the null distribution to calculate an empirical p-
value. In essence, this randomization determined how
strongly H3K4me3 was enriched in high expressed genes
relative to genes with lower levels of expression and non-
coding regions. The p-values that were produced from this
randomization were corrected for multiple testing using a
false-discovery rate (FDR) technique [56,57]. All modifi-
cations that are marked as significant in a particular region
of the genome are significant at a q-value of 0.05.
Centromeric and Telomeric Repeats
For centromeric and telomeric repeats, the consensus
sequences in RepBase [58] were used. All of the tags for
each modification were collected and compared to the
specified repeat sequence using RMAP [55]. Since RMAP is
designed as a program for aligning short sequencing reads
to a genome, it needed to be used in a modified fashion.
The "genome" that the reads were compared to was the
consensus sequence for either centromere or telomere
repeats. Thus, running RMAP with the entire list of
H3K9me3 reads and the telomere repeat sequence, would
give the number of H3K9me3 reads that mapped to the
telomere repeat. This count was then divided by the total
number of H3K9me3 reads to give the percentage of reads
mapping to telomeres. A percentage was used in order to
correct for differences between the read libraries for the
different histone modifications that could be affected by
many different factors including antibody specificity and
the number of sequencing runs performed. If there were
twice as many reads for modification A as for modifica-
tion B, the percentages would still be directly comparable
because modification A would have twice as many total
reads along with twice as many telomere reads which
would produce the same percentage or mapped reads.
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